References
- Howdle P D, Losowsky M S. Coeliac disease. Gut defences in clinical practice, M S Losowsky, R V Heatley. Churchill Livingstone, Edinburgh 1986; 243–254
- Corazza G R, Tabacchi P, Frisoni M, Prati C, Gas-Barrini G. DR and non-DR Ia allotypes are associated with susceptibilitv to coeliac disease. Gut 1985; 26: 1210–1213
- Kagnoff M F, Austin R K, Hubert J J, Bernardin J E. Kaiarda DD'. Possible role for a human adenovirus in the pathogenesis of coeliac disease. J Exp Med 1984; 160: 1544–1547
- Karagiannis J A, Priddle J D, Jewell D P. Cell-mediated immunity to a synthetic gliadin peptide resembling a sequence from adenovirus 12. Lancet 1987; 1: 884–886
- Fry H M, Grayston J T. Adenoviruses. Virus infections of humans. Epidemiology and control, A S Evans. Plenum, New York 1984; 67–84
- Kagnoff M F, Paterson Y J, Kumar P J, Kasarda D D, Carbone F R, Unsworth D J, Austin R K. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987; 28: 995–1001
- Tooze J. Molecular biology of tumour viruses. DNA tumour viruses. 2nd ed. Cold Spring Harbor Laboratory, New York 1981; 547–575
- Sawada Y, Fohring B, Shenk T E, Raska K. Tumo-rigenicity of Adenovirus-transformed cells: region EIA of adenovirus 12 confers resistance to natural killer cells. Virology 1985; 147: 41–21
- Blair Zajdel M E, Barker M D, Dixon S C, Blair G E. The use of monoclonal antibodies to study the proteins specified by the transforming region of human adenoviruses. Biochem J 1985; 225: 649–655
- Laskey R A. The use of intensifying screens, or organic scintillators, for visualizing radioactive molecules resolved by gel electrophoresis. Meth Enzymol 1980; 65: 363–371
- Wood G M, Trejdosiewicz L K, Losowsky M S. ELISA for measurement of secretory IgA distinct from monomeric IgA. J Immunol Methods 1987; 97: 269–274